CUE SCHEDULE 13G: SEC filing

Balyasny Asset Management L.P. and affiliated reporting persons

Filed with the SEC on · accession 0001172661-26-005042

CUE filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. Balyasny Asset Management L.P. and affiliated reporting persons filed a Schedule 13G disclosing beneficial ownership of 427,231 shares, or approximately 5.88%, of Cue Biopharma's common stock as of September 30, 2026. The stock moved -12.5% by the first close after the filing.

Summary of the filing

Balyasny Asset Management L.P. and affiliated reporting persons filed a Schedule 13G disclosing beneficial ownership of 427,231 shares, or approximately 5.88%, of Cue Biopharma's common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

Key details

Shares beneficially owned$427K
Percentage of class beneficially owned$6
Reporting person / investment managerBalyasny Asset Management L.P.
IssuerCue Biopharma, Inc.
Direct holder of the reported sharesAtlas Diversified Master Fund, Ltd.
Managing member of dames gp llcDmitry Balyasny
Authorized signatory, balyasny asset management l.p.Scott Schroeder

How CUE stock reacted

Close before

$16.12

Nov 13, 2026

First close after

-12.53%

$14.10

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CUE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CUE?

Click here

Frequently asked questions

What did CUE file with the SEC on Nov 16, 2026?

CUE filed a SCHEDULE 13G (SEC filing). Balyasny Asset Management L.P. and affiliated reporting persons filed a Schedule 13G disclosing beneficial ownership of 427,231 shares, or approximately 5.88%, of Cue Biopharma's common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did CUE stock react to this filing?

CUE closed at $16.12 before the filing and $14.10 on Nov 16, 2026 (-12.53%).

Other CUE SEC filings

Get alerts when CUE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days